Relation of serum levels of mast cell tryptase of left ventricular systolic function, left ventricular volume or congestive heart failure

Journal of Cardiac Failure

Volumn 10, Issue 1, 2004, Pages 31-35

  Upadhya, Bharathi ^a   Kontos, Jimmy L ^b   Ardeshirpour, Farhad ^c   Pye, Joseph ^c   Boucher, William S ^d   Theoharides, Theoharis C ^d   Dehmer, Gregory J ^e   Deliargyris, Efthymios N ^a,f  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TEXAS A M COLLEGE OF MEDICINE   (United States)

^f ATHENS MEDICAL CENTER   (Greece)

Author keywords

cardiomyopathy; coronary artery disease; cytokines; Inflammation

Indexed keywords

TRYPTASE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME SPECIFICITY; FEMALE; HEART CATHETERIZATION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE CONTRACTION; HUMAN; MALE; MAST CELL; MEDICAL EXAMINATION; PRIORITY JOURNAL;

CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CYTOKINES; FEMALE; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MAST CELLS; MIDDLE AGED; SERINE ENDOPEPTIDASES; STROKE VOLUME; TRYPTASES; VENTRICULAR FUNCTION, LEFT;

EID: 3042772200     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(03)00586-4     Document Type: Article

References (28)

1. Mukherjee D., Sen S. Alteration of collagen phenotypes in ischemic cardiomyopathy. J Clin Invest. 88:1991;1141-1146
2. Marone G., de Crescenzo G., Adt M., Patella V., Arbustini E., Genovese A. Immunological characterization and functional importance of human heart mast cells. Immunopharmacology. 31:1995;1-18
3. Patella V., Marino I., Arbustini E., Lamparter-Schummert B., Verga L., Adt M., et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation. 97:1998;971-978
4. Patella V., de Crescenzo G., Lamparter-Schummert B., De Rosa G., Adt M., Marone G. Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy. Inflamm. Res. 46:(Suppl. I):1997;31-32
5. Patella V. Human heart mast cells: a definitive case of mast cell heterogeneity. Int Arch Allergy Immunol. 106:1995;386-393
6. Marone G. Immunological modulation of human cardiac mast cells. Neurochem Res. 24:1999;1195-1202
7. Hatamochi A., Fujiwara K., Ueki H. Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. Arch Dermatol Res. 277:1985;60-64
8. Baud L., Perez J., Denis M., Ardaillou R. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J Immunol. 138:1987;1190-1195
9. Ruoss S.J., Hartmann T., Caughey G.H. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest. 88:1991;493-499
10. Theoharides T.C. The mast cell: a neuroimmunoendocrine master player. Int J Tissue React. 18:1996;1-21
11. Lees M., Taylor D.J., Woolley D.E. Mast cell proteinases activate precursor of collagenase and stromelysin but not of gelatinases A and B. Eur J Biochem. 223:1994;171-177
12. Gruber B.L., Marchese M.J., Suzuki K., Okada Y., Nagase H., Ramamurthy N.S. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloprotienase 3 activation. J Clin Invest. 84:1989;1657-1662
13. Tsutamoto T., Hisanaga T., Wada A., Maeda K., Ohnishi M., Fukai D., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 31:1998;391-398
14. Petretta M., Condorelli G.L., Spinelli L., Scopacasa F., De Caterina M., Leosco D., et al. Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure. Am Heart J. 140:2000;E28
15. MacGowan G.A., Mann D.L., Kormos R.L., Feldman A.M., Murali S. Circulating interleukin-6 in severe heart failure. Am J Cardiol. 79:1997;1128-1131
16. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236-241
17. Roig E., Orus J., Pare C., Azqueta M., Filella X., Perez-Villa F., et al. Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol. 82:1998;688-690
18. Raymond R.J., Dehmer G.J., Theoharides T.C., Deliargyris E.N. Elevated Interleukin-6 patients with asymptomatic mild to moderate left ventricular dysfunction. Am Heart J. 141:2001;435-438
19. Deliargyris E.N., Raymond R.J., Theoharides T.C., Boucher W.S., Tate D.A., Dehmer G.J. Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with Congestive cardiac failure. Am J Cardiol. 86:2000;913-918
20. Wynne J., Green L.H., Mann T. Estimation of left ventricular volumes in man from biplane cineangiograms filmed in oblique projections. Am J Cardiol. 41:1978;726-732
21. Deliargyris E.N., Dehmer G.J., Tate D.A., Smith S.C. Jr., Boucher W.S., Theoharides T.C. Elevated levels of mast cell mediators in the coronary circulation of patients with coronary artery disease. Atherosclerosis. 144:(Suppl. I):1999;I-12
22. Deliargyris E.N., Kontos J.L., Dehmer G.J., Boucher W.S., Theoharide T.C. Tryptase, a novel modulator of fibrinogen activity is elevated in patients with coronary artery disease. Blood Coag Fibrinol. 10:(Suppl.):1999;S-108
23. Theoharides T.C., Boucher W., Spear K. Serum interleukin reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol. 128:2002;344-350
24. Yamauchi-Takihara K., Ihara Y., Ogata A., Yoshizaki K., Azuma J., Kishimoto T. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 91:1995;1520-1524
25. Frangogiannis N.G., Shimoni S., Chang S.M., Ren G., Shan K., Aggeli C., et al. Evidence for an active inflammatory process in the hibernating human myocardium. Am J Pathol. 160:2002;1425-1433
26. Kovanen P.T. Role of mast cells in atherosclerosis. Chem Immunol. 62:1995;132-170
27. Kelley J.L., Chi D.S., Abou-Auda W., Smith J.K., Krishnaswamy G. The molecular role of mast cells in atherosclerotic cardiovascular disease. Mol Med Today. 6:2000;304-308
28. Huang M., Pang X., Letourneau R., Boucher W., Theoharides T.C. Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in Apolipoprotein E knockout mice. Cardiovasc Res. 55:2002;150-160